Synapse - Martin Fleisher

Results (312)

A pilot study comparing the sensitivity of detecting prostate associated transcripts by adna test prostate assay to cell search in whole blood from patients with castration resistant prostate cancer

Meeting Abstract

Samoila, A.; Wan, M.; Anand, A.; Chuang, T.; Scher, H. I.; Fleisher, M.; Danila, D. C.
Journal of Molecular Diagnostics (2012)

Fulltext@MSK | Save

NADiA prosvue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy

Journal Article

Moul, J. W.; Lilja, H.; Semmes, O. J.; Lance, R. S.; Vessella, R. L.; Fleisher, M.; Mazzola, C.; Sarno, M. J.; Stevens, B.; Klem, R. E.; more...
Urology (2012)

Fulltext@MSK | Save

Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors

Journal Article

Mitsiades, N.; Sung, C. C.; Schultz, N.; Danila, D. C.; He, B.; Eedunuri, V. K.; Fleisher, M.; Sander, C.; Sawyers, C. L.; Scher, H. I.
Cancer Research (2012)

Fulltext@MSK | Save

The analytical validation of prostate specific mRNA detection in whole blood by reverse transcription-polymerase chain reaction (RT-PCR) as a prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)

Meeting Abstract

Danila, D.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
Annals of Oncology (2012)

Fulltext@MSK | Save

Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: A prospective, two-stage study

Journal Article

Olmos, D.; Brewer, D.; Clark, J.; Danila, D. C.; Parker, C.; Attard, G.; Fleisher, M.; Reid, A. H. M.; Castro, E.; Sandhu, S. K.; more...
Lancet Oncology (2012)

Fulltext@MSK | Save

Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving Bisphosphonates for bone metastases

Journal Article

Morris, P. G.; Fazio, M.; Farooki, A.; Estilo, C.; Mallam, D.; Conlin, A.; Patil, S.; Fleisher, M.; Cremers, S.; Huryn, J.; more...
Journal of Oral and Maxillofacial Surgery (2012)

Fulltext@MSK | Save

The microculture-kinetic (MiCK) assay: The role of a drug-induced apoptosis assay in drug development and clinical care

Journal Article

Bosserman, L.; Prendergast, F.; Herbst, R.; Fleisher, M.; Salom, E.; Strickland, S.; Raptis, A.; Hallquist, A.; Perree, M.; Rajurkar, S.; more...
Cancer Research (2012)

Fulltext@MSK | Save

Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett's associated esophageal adenocarcinoma

Journal Article

Rizk, N. P.; Servais, E. L.; Tang, L. H.; Sima, C. S.; Gerdes, H.; Fleisher, M.; Rusch, V. W.; Adusumilli, P. S.
Cancer Epidemiology Biomarkers and Prevention (2012)

Fulltext@MSK | Save

Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel

Meeting Abstract

Scher, H. I.; Heller, G.; Molina, A.; Kheoh, T. S.; Attard, G.; Moreira, J.; Sandhu, S. K.; Parker, C.; Logothetis, C.; McCormack, R. T.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

A six-gene panel that predicts survival in men with castration-resistant prostate cancer

Meeting Abstract

Subudhi, S. K.; Heller, G.; Anand, A.; Danila, D. C.; Fleisher, M.; Scher, H. I.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save